{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:22:46Z","timestamp":1754194966099},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:00:00Z","timestamp":1204588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s12185-008-0055-x","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T11:59:53Z","timestamp":1204545593000},"page":"289-297","source":"Crossref","is-referenced-by-count":4,"title":["Successful autologous peripheral blood stem cell transplantation in a Jehovah\u2019s Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products"],"prefix":"10.1007","volume":"87","author":[{"given":"S.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mailaender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wiesneth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Moehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,4]]},"reference":[{"issue":"2","key":"55_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335(2):91\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"55_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1008252227512","volume":"8","author":"H Goldschmidt","year":"1997","unstructured":"Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, et al. High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Ann Oncol. 1997;8(3):243\u20136.","journal-title":"Ann Oncol"},{"issue":"Suppl. 1\/96","key":"55_CR3","first-page":"6","volume":"2","author":"H Goldschmidt","year":"1996","unstructured":"Goldschmidt H, Haas R, Hegenbart U, Wallmeier M, Egerer G, Moos M, et al. Hochdosischemotherapie beim multiplen myelom. Der Onkologe. 1996;2(Suppl. 1\/96):6\u201312.","journal-title":"Der Onkologe"},{"issue":"9","key":"55_CR4","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood.V91.9.3509","volume":"91","author":"SH Bernstein","year":"1998","unstructured":"Bernstein SH, Nademanee AP, Vose JM, Tricot G, Fay JW, Negrin RS, et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood. 1998;91(9):3509\u201317.","journal-title":"Blood"},{"issue":"5","key":"55_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1537-2995.1994.34594249050.x","volume":"34","author":"MK Viele","year":"1994","unstructured":"Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah\u2019s witnesses. Transfusion. 1994;34(5):396\u2013401.","journal-title":"Transfusion"},{"issue":"2","key":"55_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1702483","volume":"26","author":"KK Ballen","year":"2000","unstructured":"Ballen KK, Ford PA, Waitkus H, Emmons RV, Levy W, Doyle P, et al Successful autologous bone marrow transplant without the use of blood product support. Bone Marrow Transplant. 2000;26(2):227\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"55_CR7","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1200\/JCO.2004.01.144","volume":"22","author":"KK Ballen","year":"2004","unstructured":"Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA. Autologous stem-cell transplantation can be performed safely without the use of blood-product support. J Clin Oncol. 2004;22(20):4087\u201394.","journal-title":"J Clin Oncol."},{"issue":"2","key":"55_CR8","first-page":"131","volume":"27","author":"T Tenenbaum","year":"2004","unstructured":"Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, et al. Oncological management of pediatric cancer patients belonging to Jehovah\u2019s Witnesses: a two-institutional experience report. Onkologie. 2004;27(2):131\u20137.","journal-title":"Onkologie"},{"issue":"2","key":"55_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.1996.d01-1502.x","volume":"92","author":"L Pierelli","year":"1996","unstructured":"Pierelli L, Scambia G, Menichella G, d\u2019Onofrio G, Salerno G, Panici PB, et al. The combination of erythropoietin and granulocyte colony-stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation. Br J Haematol. 1996;92(2):287\u201394.","journal-title":"Br J Haematol"},{"issue":"2","key":"55_CR10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejca.2006.10.014","volume":"43","author":"C Bokemeyer","year":"2007","unstructured":"Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer. 2007;43(2):258\u201370.","journal-title":"Eur J Cancer."},{"issue":"9","key":"55_CR11","first-page":"2675","volume":"7","author":"K Neben","year":"2001","unstructured":"Neben K, Moehler T, Egerer G, Kraemer A, Hillengass J, Benner A, et al. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin Cancer Res. 2001;7(9):2675\u201381.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 5","key":"55_CR12","first-page":"75","volume":"24","author":"RM Mesters","year":"2001","unstructured":"Mesters RM, Padro T, Steins M, Bieker R, Retzlaff S, Kessler T, et al. [Angiogenesis in patients with hematologic malignancies]. Onkologie. 2001;24(Suppl 5):75\u201380.","journal-title":"Onkologie"},{"issue":"2","key":"55_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2004.04879.x","volume":"125","author":"A Waage","year":"2004","unstructured":"Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, et al. Early response predicts thalidomide efficiency in patients with advanced multiple myeloma. Br J Haematol. 2004;125(2):149\u201355.","journal-title":"Br J Haematol"},{"issue":"4","key":"55_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00000658-199010000-00014","volume":"212","author":"C Sugawa","year":"1990","unstructured":"Sugawa C, Steffes CP, Nakamura R, Sferra JJ, Sferra CS, Sugimura Y, et al. Upper GI bleeding in an urban hospital. Etiology, recurrence, and prognosis. Ann Surg. 1990;212(4):521\u20136.","journal-title":"Ann Surg"},{"issue":"4","key":"55_CR15","first-page":"568","volume":"90","author":"RT Yavorski","year":"1995","unstructured":"Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 1995;90(4):568\u201373.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"55_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jca.20043","volume":"21","author":"EA Burgstaler","year":"2006","unstructured":"Burgstaler EA. Blood component collection by apheresis. J Clin Apher. 2006;21(2):142\u201351.","journal-title":"J Clin Apher"},{"issue":"10","key":"55_CR17","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","volume":"91","author":"H Wandt","year":"1998","unstructured":"Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, et al. Safety and cost effectiveness of a 10\u00a0\u00d7\u00a010(9)\/L trigger for prophylactic platelet transfusions compared with the traditional 20\u00a0\u00d7\u00a010(9)\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998;91(10):3601\u20136.","journal-title":"Blood"},{"issue":"5","key":"55_CR18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1634\/theoncologist.6-5-446","volume":"6","author":"H Wandt","year":"2001","unstructured":"Wandt H, Ehninger G, Gallmeier WM. New strategies for prophylactic platelet transfusion in patients with hematologic diseases. Oncologist. 2001;6(5):446\u201350.","journal-title":"Oncologist"},{"issue":"4","key":"55_CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705246","volume":"37","author":"H Wandt","year":"2006","unstructured":"Wandt H, Schaefer-Eckart K, Frank M, Birkmann J, Wilhelm M. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006;37(4):387\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"55_CR20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1537-2995.1966.tb04780.x","volume":"6","author":"I Djerassi","year":"1966","unstructured":"Djerassi I, Farber S, Roy A, Cavins J. Preparation and in vivo circulation of human platelets preserved with combined dimethylsulfoxide and dextrose. Transfusion. 1966;6(6):572\u201376.","journal-title":"Transfusion"},{"issue":"3","key":"55_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1537-2995.1975.15375160355.x","volume":"15","author":"SL Raymond","year":"1975","unstructured":"Raymond SL, Pert JH, Dodds WJ. Evaluation of platelet cryopreservation techniques by isolated kidney perfusion. Transfusion. 1975;15(3):219\u201325.","journal-title":"Transfusion"},{"issue":"1","key":"55_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM197807062990102","volume":"299","author":"CA Schiffer","year":"1978","unstructured":"Schiffer CA, Aisner J, Wiernik PH. Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med. 1978;299(1):7\u201312.","journal-title":"N Engl J Med"},{"issue":"2","key":"55_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/cryo.2001.2306","volume":"42","author":"WF Wolkers","year":"2001","unstructured":"Wolkers WF, Walker NJ, Tablin F, Crowe JH. Human platelets loaded with trehalose survive freeze-drying. Cryobiology. 2001;42(2):79\u201387.","journal-title":"Cryobiology"},{"issue":"1","key":"55_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1537-2995.1997.37197176944.x","volume":"37","author":"S Holme","year":"1997","unstructured":"Holme S, Sawyer S, Heaton A, Sweeney JD. Studies on platelets exposed to or stored at temperatures below 20 degrees C or above 24 degrees C. Transfusion. 1997;37(1):5\u201311.","journal-title":"Transfusion"},{"key":"55_CR25","first-page":"297","volume":"30","author":"M Wiesneth","year":"1992","unstructured":"Wiesneth M, Koerner K, Funke I, Seifried E, Cardoso M, Heimpel H, et al. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia. Beitr Infusionsther. 1992;30:297\u2013300.","journal-title":"Beitr Infusionsther."},{"issue":"2","key":"55_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2141.1999.01178.x","volume":"104","author":"S Vadhan-Raj","year":"1999","unstructured":"Vadhan-Raj S, Currie LM, Bueso-Ramos C, Livesey SA, Connor J. Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO. Br J Haematol. 1999;104(2):403\u201311.","journal-title":"Br J Haematol"},{"issue":"2","key":"55_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/cryo.2000.2271","volume":"41","author":"H Xiao","year":"2000","unstructured":"Xiao H, Harvey K, Labarrere CA, Kovacs R. Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants. Cryobiology. 2000;41(2):97\u2013105.","journal-title":"Cryobiology"},{"issue":"1","key":"55_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.21958","volume":"107","author":"S Kalmadi","year":"2006","unstructured":"Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. Cancer. 2006;107(1):136\u201340.","journal-title":"Cancer"},{"issue":"3","key":"55_CR29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1302\/0301-620X.78B3.0780434","volume":"78","author":"G Benoni","year":"1996","unstructured":"Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br. 1996;78(3):434\u201340.","journal-title":"J Bone Joint Surg Br"},{"issue":"6","key":"55_CR30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9343(02)01064-1","volume":"112","author":"E Andres","year":"2002","unstructured":"Andres E, Kurtz JE, Martin-Hunyadi C, Kaltenbach G, Alt M, Weber JC, et al. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. Am J Med. 2002;112(6):460\u201364.","journal-title":"Am J Med"},{"issue":"12","key":"55_CR31","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","volume":"99","author":"P Guardiola","year":"2002","unstructured":"Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA, et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood. 2002;99(12):4370\u20138.","journal-title":"Blood"},{"issue":"15","key":"55_CR32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","volume":"42","author":"MS Aapro","year":"2006","unstructured":"Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer. 2006;42(15):2433\u20133.","journal-title":"Eur J Cancer"},{"issue":"8","key":"55_CR33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bmt.1704643","volume":"34","author":"A Olivieri","year":"2004","unstructured":"Olivieri A, Scortechini I, Capelli D, Montanari M, Lucesole M, Gini G, et al. Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. Bone Marrow Transplant. 2004;34(8):693\u2013702.","journal-title":"Bone Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0055-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T13:45:55Z","timestamp":1588427155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0055-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,4]]}}}